Gan & Lee Pharmaceuticals Hits Day High with 4.67% Surge in Stock Price

Gan & Lee Pharmaceuticals Co., Ltd. has experienced a notable increase of 4.67% on October 27, 2025, reaching an intraday high of CNY 71.88. This performance stands out against the backdrop of the China Shanghai Composite, which rose by only 0.71% on the same day. Over the past week, Gan & Lee has shown a solid gain of 3.08%, further demonstrating its resilience in the market.
The company has reported a significant growth in net sales of 9.89%, contributing to its positive results over the last eight consecutive quarters. Financial metrics indicate a robust operating cash flow of CNY 806.47 million, alongside a return on capital employed (ROCE) of 8.38%, both of which are at their highest levels. Additionally, the reduction in raw material costs by 4.36% year-over-year has positively impacted the company's financial health.

With a market capitalization of CNY 38,306 million, Gan & Lee Pharmaceuticals continues to be a prominent player in the pharmaceuticals and biotechnology industry, showcasing consistent returns and outperforming the China Shanghai Composite in recent years.